shiseido synchro skin lasting liquid foundation neutral 5

Generic: octinoxate and titanium dioxide

Labeler: shiseido americas corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name shiseido synchro skin lasting liquid foundation neutral 5
Generic Name octinoxate and titanium dioxide
Labeler shiseido americas corporation
Dosage Form EMULSION
Routes
TOPICAL
Active Ingredients

octinoxate 1.31 g/30mL, titanium dioxide 1.09 g/30mL

Manufacturer
SHISEIDO AMERICAS CORPORATION

Identifiers & Regulatory

Product NDC 58411-624
Product ID 58411-624_47b9b5e0-84a4-bb9d-e063-6294a90a2157
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M020
Listing Expiration 2027-12-31
Marketing Start 2021-01-01

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 58411624
Hyphenated Format 58411-624

Supplemental Identifiers

UNII
4Y5P7MUD51 15FIX9V2JP

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name shiseido synchro skin lasting liquid foundation neutral 5 (source: ndc)
Generic Name octinoxate and titanium dioxide (source: ndc)
Application Number M020 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 1.31 g/30mL
  • 1.09 g/30mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (58411-624-10) / 30 mL in 1 BOTTLE
source: ndc

Packages (1)

58411-624-10 1 BOTTLE in 1 CARTON (58411-624-10) / 30 mL in 1 BOTTLE

Ingredients (2)

octinoxate (1.31 g/30mL) titanium dioxide (1.09 g/30mL)

Linked Drug Pages (1)

SHISEIDO SYNCHRO SKIN LASTING Liquid FOUNDATION Neutral 5, SHISEIDO SYNCHRO SKIN LASTING Liquid FOUNDATION Rose 5, SHISEIDO SYNCHRO SKIN LASTING Liquid FOUNDATION Golden 5 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "47b9b5e0-84a4-bb9d-e063-6294a90a2157", "openfda": {"unii": ["4Y5P7MUD51", "15FIX9V2JP"], "spl_set_id": ["66c22f17-5418-42ff-97b2-33fa10f5eac3"], "manufacturer_name": ["SHISEIDO AMERICAS CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (58411-624-10)  / 30 mL in 1 BOTTLE", "package_ndc": "58411-624-10", "marketing_start_date": "20210101"}], "brand_name": "SHISEIDO SYNCHRO SKIN LASTING Liquid FOUNDATION Neutral 5", "product_id": "58411-624_47b9b5e0-84a4-bb9d-e063-6294a90a2157", "dosage_form": "EMULSION", "product_ndc": "58411-624", "generic_name": "OCTINOXATE and TITANIUM DIOXIDE", "labeler_name": "SHISEIDO AMERICAS CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "SHISEIDO SYNCHRO SKIN LASTING Liquid FOUNDATION Neutral 5", "active_ingredients": [{"name": "OCTINOXATE", "strength": "1.31 g/30mL"}, {"name": "TITANIUM DIOXIDE", "strength": "1.09 g/30mL"}], "application_number": "M020", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210101", "listing_expiration_date": "20271231"}